This article refers to:
Correction to: Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin’s lymphomas
The Publishers would like to apologize for a duplication error that unfortunately occurred in the following article:
Ohanian M, Kantarjian H, Guy D, et al. Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin’s lymphomas. Expert Opin Biol Ther. 2015;15(4):601-611.
Following publication of this article, a duplication error has been identified in “Box 1. Drug summary”.
Route of Administration Intravenous
Route of administration Intra-articular
The sentence should only have read “Route of administration Intravenous”.
This is corrected in the online version with a notice of correction.